• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.52% Nasdaq Down0.25%

    Cara Therapeutics Inc. (CARA)

    -NasdaqGM
    21.82 Up 0.51(2.39%) Aug 3, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 3,177   11,964   1,190  
    Cost of Revenue -   -   -  
    Gross Profit 3,177   11,964   1,190  
    Operating Expenses
    Research Development15,068  8,685  4,597  
    Selling General and Administrative6,181  3,516  2,829  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (18,072) (237) (6,236)
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -   -  
    Earnings Before Interest And Taxes(17,946)(3,993)(6,302)
    Interest Expense -   -   -  
    Income Before Tax(17,946)(3,993)(6,302)
    Income Tax Expense(201)(30)(31)
    Minority Interest -   -   -  
    Net Income From Continuing Ops(17,745)(3,963)(6,271)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (17,745) (3,963) (6,271)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (17,745) (3,963) (6,271)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.